Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model
about
Mechanisms of Candida biofilm drug resistanceAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsTowards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence.High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.Candida albicans biofilm development on medically-relevant foreign bodies in a mouse subcutaneous model followed by bioluminescence imaging.In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species.The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilmsRecent insights into Candida albicans biofilm resistance mechanismsThe Eagle-like effect of echinocandins: what's in a name?Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.Future therapies targeted towards eliminating Candida biofilms and associated infections.Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique.Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial Interactions.Antifungal Activity of Oleylphosphocholine on In Vitro and In Vivo Candida albicans Biofilms.Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.
P2860
Q26827521-A4CE6CBD-3EC3-4B4E-9090-5E8F8D7D7B17Q28818603-A4105891-BD37-454D-8459-E0DD5BDB0359Q33573788-726DF504-9EBB-456B-A26B-3895B74AB3BCQ34376059-DE7847DA-69C1-4E7C-BD5D-EA48107164E9Q35119312-9D995CE0-9D63-4C8E-A611-6CC6EC3BD6FBQ35162023-7736E0D3-C278-492B-9EBE-58BF407D1E2EQ35433089-F65A0100-0732-4763-BD69-F67603359E84Q35974693-241C9C59-4303-4664-B6C1-0DBC4DB6BFECQ36267962-F94F9AB3-F3AD-47DF-89A6-A2CFFBCA99F0Q36683547-04045561-9E66-41F7-B104-5E3110C12200Q37544715-E77EEDB8-F080-40FE-BBF9-BB6AC0D7FB6EQ38131290-0E4A16C2-AF1C-4607-8126-7D6AABFC25B9Q38153458-D1812564-DEAE-4EDD-BA93-24D6443C3D5EQ38535647-43AA91BA-CBC4-4F7B-B2D8-3E4A4F20F8E8Q38586680-BB70BCC0-3778-4480-81D3-45BE31CD3EDCQ38786061-5A78856E-61A8-49B0-B29F-0A6983F1C6EDQ40625328-17A30DC6-3ACF-47F8-8941-64D0ECFD90C7Q40910127-32F41D09-6066-468A-9D29-E9DACBF6C78FQ48143464-67979DA3-43F8-45B2-A40E-44FB9076E7DEQ55511181-6915F203-002D-4CE4-8BAB-7476344E5FD3
P2860
Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Activities of systemically adm ...... ed in a rat subcutaneous model
@en
type
label
Activities of systemically adm ...... ed in a rat subcutaneous model
@en
prefLabel
Activities of systemically adm ...... ed in a rat subcutaneous model
@en
P2093
P2860
P356
P1476
Activities of systemically adm ...... ed in a rat subcutaneous model
@en
P2093
Isabel Spriet
Johan Maertens
Katrien Lagrou
Nidhi Sharma
Patrick Van Dijck
Sona Kucharíková
P2860
P304
P356
10.1128/AAC.02288-12
P407
P577
2013-02-12T00:00:00Z